We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HYFM:NASDAQHydrofarm Holdings Group, Inc. analysis

Data as of Sep 1, 2026 - not real-time

Latest price
$0.93
Risk: high
9/10High risk

Summary

At $0.9311, Hydrofarm Holdings Group, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 37.3%. With RSI at 44.7 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $0.7670 up to resistance at $2.33.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 40.9% on a -267.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 438.0%, a beta of 3.53 and a maximum drawdown of 87.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.

Top market events

  • Benzinga.com3monHydrofarm Holdings Group Earnings & ForecastsHydrofarm Holdings Group HYFM last issued guidance on...
  • SHOEMAKERSVILLE, Pa., Aug. 14, 2026 GLOBE NEWSWIRE -- Hydrofarm Holdings Group, Inc. 'Hydrofarm” or the 'Company”...
  • SHOEMAKERSVILLE, Pa., Aug. 14, 2026 GLOBE NEWSWIRE -- Hydrofarm Holdings Group, Inc. "Hydrofarm" or the "Company"...

Market outlook

Short term

< 1 year

Cautious

Model confidence4/104 out of 10

Key factors

  • Trading below the 200-day average of 1.25
  • MACD momentum is negative
  • 30-day price change of +37.3%

Medium term

1–3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • Trading below the 200-day average of 1.25
  • 30-day volatility of 438.0%
  • MACD momentum is negative

Long term

> 3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • Negative profit margin of -267.2%
  • Negative return on equity of -535.5%
  • Revenue contracting at -40.9%

Key metrics

Financial health

Revenue Growth-40.90%
Profit Margin-267.20%
P/E Ratio-1.5
ROE-535.51%
ROA-9.30%
P/B Ratio-0.1
Op. Cash Flow$-4719000
Free Cash Flow$10.9M
Industry P/E28.6

Technical analysis

TrendNeutral
RSI44.7
Support$0.77
Resistance$2.33
MA 20$1.28
MA 50$1.00
MA 200$1.25
MACDBearish
VolumeDecreasing
Fear & Greed Index92.11

Valuation

GradeFair
TypeBlend

Risk assessment

Beta3.53
Volatility438.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.